Prof. Myriam Hunink

Prof. Myriam Hunink completed a BSc in applied mathematics, an MD degree, and a PhD in health decision sciences. She trained as a radiologist in Amsterdam (VUMC, NL), did subspecialty training in interventional and cardiovascular radiology in Boston (BWH, Harvard University, USA), and did a research fellowship at Harvard University (HSPH, BWH, HMS, Harvard University, USA).

She currently directs the Assessment of Radiological Technology (ART) programme and the division of Clinical Epidemiology at the Erasmus University Medical Center (EMC, NL). She is Professor of Clinical Epidemiology and Radiology at EMC and Adjunct Professor of Health Decision Sciences at the Harvard T. H. Chan School of Public Health (Harvard University, USA).

Prof. Hunink’s research focuses on comparative effectiveness and health technology assessment of strategies for the primary and secondary prevention of cardiovascular events and in particular the use of imaging biomarkers for this purpose. Her other research interests include integrated diagnostics, computerized decision support for evidence-based use of imaging tests, and imaging to measure the effectiveness of lifestyle interventions. She has longstanding experience in a wide range of methodologies, including randomised controlled trial designs, meta-analysis, decision analysis, simulation models, and comparative effectiveness & cost-effectiveness analyses and is lead author on a widely used textbook in the field.

Prof. Hunink was the PI on four large multicentre clinical studies: an RCT evaluating diagnostic imaging and an RCT evaluating percutaneous intervention both for peripheral arterial disease, a cluster RCT assessing a lifestyle program, and an observational study on the use of prediction rules for triaging minimal head injury patients to CT. She has been involved in multiple other clinical studies both as PI and as co-investigator. She has directed her own research group for over 20 years now, and chaired the Medical Research Advisory Committee at EMC for 5 years. Furthermore, she is a past president of the Society for Medical Decision Making (